Clinical Trial Update: Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials [Phase 3]

View source ↗

Summary

An open-label Phase 3 extension study of duloxetine in patients with major depressive disorder who completed prior duloxetine trials, focusing on longer-term sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED